Indonesia: WHO and UNICEF estimates of immunization ... · OFFICIAL coverage may di er across...

Indonesia: WHO and UNICEF estimates of immunization coverage: 2018 revision

July 2, 2019; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2020 data received as of June 28, 2019

Indonesia: WHO and UNICEF estimates of immunization coverage: 2018 revision

BACKGROUND NOTE: Each year WHO and UNICEF jointly review reports submitted by MemberStates regarding national immunization coverage, finalized survey reports as well as data from thepublished and grey literature. Based on these data, with due consideration to potential biases and theviews of local experts, WHO and UNICEF attempt to distinguish between situations where theavailable empirical data accurately reflect immunization system performance and those where the dataare likely to be compromised and present a misleading view of immunization coverage while jointlyestimating the most likely coverage levels for each country.

WHO and UNICEF estimates are country-specific; that is to say, each country’s data are reviewedindividually, and data are not borrowed from other countries in the absence of data. Estimates are notbased on ad hoc adjustments to reported data; in some instances empirical data are available from asingle source, usually the nationally reported coverage data. In cases where no data are available for agiven country/vaccine/year combination, data are considered from earlier and later years andinterpolated to estimate coverage for the missing year(s). In cases where data sources are mixed andshow large variation, an attempt is made to identify the most likely estimate with consideration of thepossible biases in available data. For methods see:

*Burton et al. 2009. WHO and UNICEF estimates of national infant immunization coverage: methodsand processes.*Burton et al. 2012. A formal representation of the WHO and UNICEF estimates of nationalimmunization coverage: a computational logic approach.*Brown et al. 2013. An introduction to the grade of confidence used to characterize uncertainty aroundthe WHO and UNICEF estimates of national immunization coverage.

DATA SOURCES.

ADMINISTRATIVE coverage: Reported by national authorities and based on aggregatedadministrative reports from health service providers on the number of vaccinations administeredduring a given period (numerator data) and reported target population data (denominator data).May be biased by inaccurate numerator and/or denominator data.

OFFICIAL coverage: Estimated coverage reported by national authorities that reflects theirassessment of the most likely coverage based on any combination of administrative coverage,survey-based estimates or other data sources or adjustments. Approaches to determineOFFICIAL coverage may differ across countries.

SURVEY coverage: Based on estimated coverage from population-based household surveys amongchildren aged 12-23 months or 24-35 months following a review of survey methods and results.Information is based on the combination of vaccination history from documented evidence orcaregiver recall. Survey results are considered for the appropriate birth cohort based on theperiod of data collection.

ABBREVIATIONS

BCG: percentage of births who received one dose of Bacillus Calmette Guerin vaccine.

DTP1 / DTP3: percentage of surviving infants who received the 1st / 3rd dose, respectively, ofdiphtheria and tetanus toxoid with pertussis containing vaccine.

Pol3: percentage of surviving infants who received the 3rd dose of polio containing vaccine. May beeither oral or inactivated polio vaccine.

IPV1: percentage of surviving infants who received at least one dose of inactivated polio vaccine. Incountries utilizing an immunization schedule recommending either (i) a primary series of threedoses of oral polio vaccine (OPV) plus at least one dose of IPV where OPV is included in routine

immunization and/or campaign or (ii) a sequential schedule of IPV followed by OPV, WHO andUNICEF estimates for IPV1 reflect coverage with at least one routine dose of IPV among infants<1 year of age among countries. For countries utilizing IPV containing vaccine use only, i.e., norecommended dose of OPV, the WHO and UNICEF estimate for IPV1 corresponds to coveragefor the 1st dose of IPV.

Production of IPV coverage estimates, which begins in 2015, results in no change of theestimated coverage levels for the 3rd dose of polio (Pol3). For countries recommending routineimmunization with a primary series of three doses of IPV alone, WHO and UNICEF estimatedPol3 coverage is equivalent to estimated coverage with three doses of IPV. For countries with asequential schedule, estimated Pol3 coverage is based on that for the 3rd dose of polio vaccineregardless of vaccine type.

MCV1: percentage of surviving infants who received the 1st dose of measles containing vaccine. Incountries where the national schedule recommends the 1st dose of MCV at 12 months or laterbased on the epidemiology of disease in the country, coverage estimates reflect the percentage ofchildren who received the 1st dose of MCV as recommended.

MCV2: percentage of children who received the 2nd dose of measles containing vaccine according tothe nationally recommended schedule.

RCV1: percentage of surviving infants who received the 1st dose of rubella containing vaccine. Coverage estimates are based on WHO and UNICEF estimates of coverage for the dose of measlescontaining vaccine that corresponds to the first measles-rubella combination vaccine. Nationallyreported coverage of RCV is not taken into consideration nor are the data represented in theaccompanying graph and data table.

HepBB: percentage of births which received a dose of hepatitis B vaccine within 24 hours of delivery.Estimates of hepatitis B birth dose coverage are produced only for countries with a universalbirth dose policy. Estimates are not produced for countries that recommend a birth dose toinfants born to HepB virus-infected mothers only or where there is insufficient information todetermine whether vaccination is within 24 hours of birth.

HepB3: percentage of surviving infants who received the 3rd dose of hepatitis B containing vaccinefollowing the birth dose.

Hib3: percentage of surviving infants who received the 3rd dose of Haemophilus influenzae type bcontaining vaccine.

RotaC: percentage of surviving infants who received the final recommended dose of rotavirus vaccine,which can be either the 2nd or the 3rd dose depending on the vaccine.

PcV3: percentage of surviving infants who received the 3rd dose of pneumococcal conjugate vaccine.In countries where the national schedule recommends two doses during infancy and a boosterdose at 12 months or later based on the epidemiology of disease in the country, coverageestimates may reflect the percentage of surviving infants who received two doses of PcV prior tothe 1st birthday.

YFV: percentage of surviving infants who received one dose of yellow fever vaccine in countries whereYFV is part of the national immunization schedule for children or is recommended in at riskareas; coverage estimates are annualized for the entire cohort of surviving infants.

Disclaimer: All reasonable precautions have been taken by the World Health Organization andUnited Nations Children’s Fund to verify the information contained in this publication. However,the published material is being distributed without warranty of any kind, either expressed orimplied. The responsibility for the interpretation and use of the material lies with the reader. Inno event shall the World Health Organization or United Nations Children’s Fund be liable fordamages arising from its use.


Indonesia - BCG

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate 83 80 78 88 98 88 86 82 80 81 82 81

Estimate GoC • • • • • • • • • • • •Official 92 89 93 97 97 89 92 94 90 90 93 89

Administrative 94 93 95 97 98 100 98 94 92 93 94 93Survey NA NA 78 NA 89 88 NA NA NA 87 NA NA

The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and informationthat are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describethe grade of confidence (GoC) we have in these estimates. As there is no underlying probability model uponwhich the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidenceintervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges aroundthe coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It isnot a judgment of the quality of data reported by national authorities.

••• Estimate is supported by reported data [R+], coverage recalculated with an independent denominatorfrom the World Population Prospects: 2017 revision from the UN Population Division (D+), and atleast one supporting survey within 2 years [S+]. While well supported, the estimate still carries a riskof being wrong.

•• Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or[S-], challenges the estimate.

• There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate.

In all cases these estimates should be used with caution and should be assessed in lightof the objective for which they are being used.

Description:

2018: Reported data calibrated to 2012 levels. WHO and UNICEF are aware of a 2017 DHSsurvey and await final results. Preliminary results support official reported data for the2016 birth cohort. See results below for 2016. Adjustments used to obtain reported offi-cial government estimate is unexplained. Calibration applied to administrative coveragelevels. Estimate challenged by: D-R-

2017: Reported data calibrated to 2012 levels. Adjustments used to obtain reported official gov-ernment estimate is unexplained. Calibration applied to administrative coverage levels.Estimate challenged by: D-R-

2016: Reported data calibrated to 2012 levels. Indonesia Laporan Nasional Riskesdas 2018 re-sults ignored by working group. Internal, external, and historical trend inconsistenciesobserved in Riskesdas 2018 survey values. Preliminary results of Indonesia Demographicand Health Survey 2017 is 91 percent. Adjustments used to obtain reported official gov-ernment estimate is unexplained. Calibration applied to administrative coverage levels.Estimate challenged by: D-R-


2014: Reported data calibrated to 2012 levels. Programme reports six month stock-out dur-ing first half of year. Calibration applied to administrative coverage levels. Estimatechallenged by: R-

2013: Reported data calibrated to 2012 levels. Calibration applied to administrative coveragelevels. Estimate challenged by: R-

2012: Survey evidence does not support reported data. Estimate based on survey results. Sur-vey evidence of 88 percent based on 1 survey(s). Calibration applied to administrativecoverage levels. Estimate challenged by: R-

2011: Estimate based on administrative data reported by national government supported bysurvey. Survey evidence of 89 percent based on 1 survey(s). Calibration applied toadministrative coverage levels. Estimate challenged by: S-

2010: Reported data calibrated to 2009 and 2011 levels. Calibration applied to administrativecoverage levels. Estimate challenged by: R-

2009: Survey evidence does not support reported data. Estimate based on survey results. Sur-vey evidence of 78 percent based on 1 survey(s). Calibration applied to administrativecoverage levels. Estimate challenged by: D-R-S-

2008: Reported data calibrated to 2006 and 2009 levels. Calibration applied to administrativecoverage levels. Estimate challenged by: D-R-

2007: Reported data calibrated to 2006 and 2009 levels. Estimate challenged by: R-


Indonesia - DTP1

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate 85 88 88 89 88 87 86 85 85 85 86 85


Administrative 96 96 97 98 98 103 101 95 95 95 96 95Survey NA NA NA NA 88 NA NA NA NA 65 NA NA






Description:

2018: Reported data calibrated to 2011 levels. WHO and UNICEF are aware of a 2017 DHSsurvey and await final results. Preliminary results support official reported data for the2016 birth cohort. See results below for 2016. Adjustments used to obtain reported offi-cial government estimate is unexplained. Calibration applied to administrative coveragelevels. Estimate challenged by: R-

2017: Reported data calibrated to 2011 levels. Adjustments used to obtain reported official gov-ernment estimate is unexplained. Calibration applied to administrative coverage levels.Estimate of 86 percent changed from previous revision value of 96 percent. Estimatechallenged by: R-

2016: Reported data calibrated to 2011 levels. Indonesia Laporan Nasional Riskesdas 2018 re-sults ignored by working group. Internal, external, and historical trend inconsistenciesobserved in Riskesdas 2018 survey values. Preliminary results of Indonesia Demographicand Health Survey 2017 is 89 percent. Adjustments used to obtain reported official gov-ernment estimate is unexplained. Calibration applied to administrative coverage levels.Estimate of 85 percent changed from previous revision value of 95 percent. Estimatechallenged by: R-

2015: Reported data calibrated to 2011 levels. Adjustments used to obtain reported official gov-ernment estimate is unexplained. Calibration applied to administrative coverage levels.Estimate of 85 percent changed from previous revision value of 95 percent. Estimatechallenged by: R-

2014: Reported data calibrated to 2011 levels. Programme reports four month stock-out duringfirst half of year. Estimates based on a calibration applied to administrative coverage lev-els. Estimate of 85 percent changed from previous revision value of 95 percent. Estimatechallenged by: R-

2013: Reported data calibrated to 2011 levels. Reported data excluded because 101 percentgreater than 100 percent. Estimates based on a calibration applied to administrativecoverage levels. Estimate of 86 percent changed from previous revision value of 96 per-cent. Estimate challenged by: R-

2012: Reported data calibrated to 2011 levels. Reported data excluded because 103 percentgreater than 100 percent. Estimates based on a calibration applied to administrativecoverage levels. Estimate of 87 percent changed from previous revision value of 97 per-cent. Estimate challenged by: R-

2011: Estimate of 88 percent assigned by working group. Estimate is based on survey result.Estimates based on a calibration applied to administrative coverage levels. Estimate of88 percent changed from previous revision value of 98 percent. Estimate challenged by:R-

2010: Reported data calibrated to 2006 and 2011 levels. Estimates based on a calibration appliedto administrative coverage levels. Estimate of 89 percent changed from previous revisionvalue of 97 percent. Estimate challenged by: R-

2009: Reported data calibrated to 2006 and 2011 levels. Estimates based on a calibration appliedto administrative coverage levels. Estimate of 88 percent changed from previous revision


Indonesia - DTP1

value of 94 percent. Estimate challenged by: R-2008: Reported data calibrated to 2006 and 2011 levels. Estimates based on a calibration applied

to administrative coverage levels. Estimate of 88 percent changed from previous revisionvalue of 92 percent. Estimate challenged by: R-

2007: Reported data calibrated to 2006 and 2011 levels. Estimate of 85 percent changed fromprevious revision value of 87 percent. Estimate challenged by: D-R-


Indonesia - DTP3

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate 73 77 78 81 81 83 85 78 78 79 79 79








Description:





2014: Reported data calibrated to 2011 levels. Programme reports four month stock-out dur-ing first half of year. Calibration applied to administrative coverage levels. Estimatechallenged by: D-R-


2012: Reported data calibrated to 2011 levels. Indonesia Basic Health Survey (RISKES-DAS) 2013 results ignored by working group. Insufficient evidence to correct for recallbias.Reported data excluded because 101 percent greater than 100 percent. Calibrationapplied to administrative coverage levels. Estimate challenged by: R-

2011: Survey evidence does not support reported data. Estimate based on survey results. Surveyevidence of 81 percent based on 1 survey(s). Indonesia Demographic and Health Survey2012 card or history results of 72 percent modifed for recall bias to 81 percent based on1st dose card or history coverage of 88 percent, 1st dose card only coverage of 40 percentand 3rd dose card only coverage of 37 percent. Calibration applied to administrativecoverage levels. Estimate challenged by: D-R-


2009: Reported data calibrated to 2006 and 2011 levels. Indonesia Basic Health Survey (RISKES-DAS) 2010 results ignored by working group. Insufficient evidence to correct for recallbias. Calibration applied to administrative coverage levels. Estimate challenged by: D-R-


2007: Reported data calibrated to 2006 and 2011 levels. Estimate challenged by: D-R-


Indonesia - Pol3

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate 77 83 85 82 81 84 86 80 80 80 80 80








Description:



2016: Reported data calibrated to 2011 levels. Indonesia Laporan Nasional Riskesdas 2018 re-sults ignored by working group. Internal, external, and historical trend inconsistenciesobserved in Riskesdas 2018 survey values. Programme reports three month vaccine stock-out at national level. Preliminary results of Indonesia Demographic and Health Survey2017 is 83 percent. Adjustments used to obtain reported official government estimate isunexplained. Calibration applied to administrative coverage levels. Estimate challengedby: D-R-


2014: Reported data calibrated to 2011 levels. Programme reports six month stock-out dur-ing first half of year. Calibration applied to administrative coverage levels. Estimatechallenged by: D-R-


2012: Reported data calibrated to 2011 levels. Indonesia Basic Health Survey (RISKES-DAS) 2013 results ignored by working group. Insufficient evidence to correct for recallbias.Reported data excluded because 102 percent greater than 100 percent. Calibrationapplied to administrative coverage levels. Estimate challenged by: R-

2011: Estimate of 81 percent assigned by working group. Based on DTP survey results adjustedfor recall bias. Indonesia Demographic and Health Survey 2012 results ignored by work-ing group. Survey result likely includes polio doses administered during supplementaryimmunization activities.Indonesia Demographic and Health Survey 2012 card or historyresults of 76 percent modifed for recall bias to 84 percent based on 1st dose card orhistory coverage of 91 percent, 1st dose card only coverage of 41 percent and 3rd dosecard only coverage of 38 percent. Calibration applied to administrative coverage levels.Estimate challenged by: R-


2009: Reported data calibrated to 2006 and 2011 levels. Indonesia Basic Health Survey (RISKES-DAS) 2010 results ignored by working group. Insufficient evidence to correct for recallbias. Calibration applied to administrative coverage levels. Estimate challenged by: R-

2008: Reported data calibrated to 2006 and 2011 levels. Calibration applied to administrative


Indonesia - Pol3

coverage levels. Estimate challenged by: R-2007: Reported data calibrated to 2006 and 2011 levels. Estimate challenged by: D-R-


Indonesia - IPV1

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate NA NA NA NA NA NA NA NA NA 2 47 66

Estimate GoC NA NA NA NA NA NA NA NA NA • • •Official NA NA NA NA NA NA NA NA NA NA NA 66

Administrative NA NA NA NA NA NA NA NA NA 2 47 66Survey NA NA NA NA NA NA NA NA NA NA NA NA






Description:

Estimates for a dose of inactivated polio vaccine (IPV) begin in 2015 following the Global Po-lio Eradication Initiative’s Polio Eradication and Endgame Strategic Plan: 2013-2018which recommended at least one full dose or two fractional doses of IPV into routineimmunization schedules as a strategy to mitigate the potential consequences should anyre-emergence of type 2 poliovirus occur following the planned withdrawal of Sabin type2 strains from oral polio vaccine (OPV).

2018: Estimate based on coverage reported by national government. Estimate exceptionallybased on reported coverage following introduction. GoC=Assigned by working group.Consistency with GoC for other vaccines.

2017: Estimate based on reported administrative estimate. Estimate exceptionally based on re-ported coverage following introduction. GoC=Assigned by working group. Consistencywith GoC for other vaccines.

2016: Estimate based on reported administrative estimate. Inactivated polio vaccine intro-duced in 2016. Estimate exceptionally based on reported coverage following introduction.GoC=Assigned by working group. Consistency with GoC for other vaccines.


Indonesia - MCV1

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate 76 76 74 78 80 82 81 75 75 76 75 75








Description:





2014: Reported data calibrated to 2012 levels. Programme reports two month stock-out dur-ing first half of year. Calibration applied to administrative coverage levels. Estimatechallenged by: D-R-

2013: Reported data calibrated to 2012 levels. Calibration applied to administrative coveragelevels. Estimate challenged by: D-R-

2012: Survey evidence does not support reported data. Estimate based on survey results. Sur-vey evidence of 82 percent based on 1 survey(s). Calibration applied to administrativecoverage levels. Estimate challenged by: R-

2011: Survey evidence does not support reported data. Estimate based on survey results. Sur-vey evidence of 80 percent based on 1 survey(s). Calibration applied to administrativecoverage levels. Estimate challenged by: D-R-


2009: Survey evidence does not support reported data. Estimate based on survey results. Sur-vey evidence of 74 percent based on 1 survey(s). Calibration applied to administrativecoverage levels. Estimate challenged by: D-R-




Indonesia - MCV2

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate 73 66 67 74 76 78 76 28 31 55 63 67

Estimate GoC • • • • • • • •• • • • •Official 85 78 NA 85 85 81 NA NA NA 55 NA 52

Administrative 87 81 85 90 90 92 93 28 31 56 63 67Survey NA NA NA NA NA NA NA NA NA 38 NA NA






Description:

Coverage estimates for the second dose of measles containing vaccine are for children by thenationally recommended age.

2018: Estimate based on reported administrative data. Estimate exceptionally based on reportedcoverage following change in schedule. Estimate is based on reported administrative cov-erage. GoC=Assigned by working group. Consistency with GoC for other vaccines.

2017: Estimate based on reported administrative data. Estimate exceptionally based on reportedcoverage following change in schedule. GoC=Assigned by working group. Consistencywith GoC for other vaccines.

2016: Estimate based on coverage reported by national government. Indonesia Laporan NasionalRiskesdas 2018 results ignored by working group. Internal, external, and historical trendinconsistencies observed in Riskesdas 2018 survey values. Estimate is based on reportedadministrative coverage following change in schedule. GoC=Assigned by working group.Consistency with GoC for other vaccines.

2015: Estimate based on reported administrative data. No explanation provided for continuedlow levels of reported coverage for second dose of MCV following change in schedule.Reported target population appears to cover multiple birth cohorts. Estimate challengedby: D-

2014: Decline in administrative coverage reflects change in reporting for children under 3 yearsfollowing a transition in the recommended schedule. School-based administration to chil-dren aged 6-7 years was 92 percent during 2014, similar to levels reported in prior yearsfor this age group. GoC=R+ D+

2013: Estimate of 76 percent assigned by working group. Estimate follows reported data cali-brated based on MCV adjustment factor. Calibration applied to administrative coveragelevels. Estimate challenged by: D-R-







Indonesia - MCV2

2007: Estimate of 73 percent assigned by working group. Estimate follows reported data cali-brated based on MCV adjustment factor. Estimate challenged by: R-


Indonesia - RCV1

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate NA NA NA NA NA NA NA NA NA NA 15 40

Estimate GoC NA NA NA NA NA NA NA NA NA NA • •Official NA NA NA NA NA NA NA NA NA NA NA NA

Administrative NA NA NA NA NA NA NA NA NA NA NA NASurvey NA NA NA NA NA NA NA NA NA NA NA NA






Description:

For this revision, coverage estimates for the first dose of rubella containing vaccine are basedon WHO and UNICEF estimates of coverage of measles containing vaccine. Nationallyreported coverage of rubella containing vaccine is not taken into consideration nor arethey represented in the the accompanying graph and data table.

2018: Rubella containing vaccine continues to be partially introduced across the country. Es-timates is based on an adjustment to the reported administrative data based on thedifference between estimated and reported coverage for MCV1. Estimate challenged by:D-R-

2017: Programme introduce rubella-containing vaccine in part of the country. Estimate chal-lenged by: D-R-


Indonesia - HepBB

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate NA NA NA NA NA NA NA NA NA NA 32 54

Estimate GoC NA NA NA NA NA NA NA NA NA NA • •Official 83 52 68 75 80 80 84 86 82 NA NA 54

Administrative 54 60 68 76 81 86 87 86 85 NA 32 55Survey NA NA NA NA 85 NA NA NA NA 83 NA NA






Description:

2018: Estimate based on coverage reported by national government. Estimate exceptionallybased on reported coverage. GoC=Assigned by working group. Consistency with GoCfor other vaccines.

2017: Estimate based on reported administrative estimate. Estimate exceptionally based on re-ported coverage. Beginning in 2017 the Programme reports doses given within 24 hoursseparate from later doses. GoC=Assigned by working group. Consistency with GoC forother vaccines.


Indonesia - HepB3

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate 76 82 82 83 81 83 85 78 78 79 79 79








Description:



2016: Estimate of 79 percent assigned by working group. Estimate is based on estimated DTP3level. Indonesia Laporan Nasional Riskesdas 2018 results ignored by working group. In-ternal, external, and historical trend inconsistencies observed in Riskesdas 2018 surveyvalues. Preliminary results of Indonesia Demographic and Health Survey 2017 is 77 per-cent. Adjustments used to obtain reported official government estimate is unexplained.Calibration applied to administrative coverage levels. Estimate challenged by: D-R-

2015: Estimate of 78 percent assigned by working group. Estimate is based on estimated DTP3level. Adjustments used to obtain reported official government estimate is unexplained.Calibration applied to administrative coverage levels. Estimate challenged by: D-R-

2014: Estimate of 78 percent assigned by working group. Estimate is based on estimated DTP3level. Programme reports four month stock-out during first half of year. Calibrationapplied to administrative coverage levels. Estimate challenged by: D-R-


2012: Reported data calibrated to 2011 and 2014 levels. Indonesia Basic Health Survey (RISKES-DAS) 2013 results ignored by working group. Insufficient evidence to correct for recallbias.Reported data excluded because 101 percent greater than 100 percent. Calibrationapplied to administrative coverage levels. Estimate challenged by: R-

2011: Estimate of 81 percent assigned by working group. Based on DTP survey results adjustedfor recall bias. Indonesia Demographic and Health Survey 2012 results ignored by work-ing group. Survey results for HepB3 inconsistent with DTP3 while vaccine presentationis DTP-HepB tetravalent vaccine.Indonesia Demographic and Health Survey 2012 cardor history results of 42 percent modifed for recall bias to 58 percent based on 1st dosecard or history coverage of 74 percent, 1st dose card only coverage of 37 percent and 3rddose card only coverage of 29 percent. Calibration applied to administrative coveragelevels. Estimate challenged by: D-R-


2009: Reported data calibrated to 2006 and 2011 levels. Indonesia Basic Health Survey (RISKES-DAS) 2010 results ignored by working group. Insufficient evidence to correct for recallbias. Calibration applied to administrative coverage levels. Estimate challenged by: D-R-

2008: Reported data calibrated to 2006 and 2011 levels. Calibration applied to administrativecoverage levels. Estimate challenged by: R-S-


Indonesia - HepB3



Indonesia - Hib3

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate NA NA NA NA NA NA 4 30 78 79 79 79

Estimate GoC NA NA NA NA NA NA • • • • • •Official NA NA NA NA NA NA NA NA NA 85 85 79

Administrative NA NA NA NA NA NA 36 44 93 93 93 93Survey NA NA NA NA NA NA NA NA NA 61 NA NA






Description:



2016: Estimate of 79 percent assigned by working group. Estimate is based on estimated DTP3level. Indonesia Laporan Nasional Riskesdas 2018 results ignored by working group. In-ternal, external, and historical trend inconsistencies observed in Riskesdas 2018 surveyvalues. Preliminary results of Indonesia Demographic and Health Survey 2017 is 77 per-cent. Adjustments used to obtain reported official government estimate is unexplained.Calibration applied to administrative coverage levels. Estimate challenged by: D-R-

2015: Estimate of 78 percent assigned by working group. Reported data based on national targetpopulation. Estimate is based on estimated DTP3 level. Adjustments used to obtain re-ported official government estimate is unexplained. Calibration applied to administrativecoverage levels. Estimate challenged by: D-R-

2014: Estimate of 30 percent assigned by working group. Reported data based on national targetpopulation. Estimate is based on calibrated DTP3 level. Estimate challenged by: D-R-

2013: Estimate of 4 percent assigned by working group. DTP-HepB-Hib pentavalent combinationvaccine introduced in part of the country in August 2013. Thirty-six percent coverageachieved in 24 percent of national target population. Estimate challenged by: R-


Indonesia - RotaC

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate NA NA NA NA NA NA NA NA NA NA NA NA

Estimate GoC NA NA NA NA NA NA NA NA NA NA NA NA

Official NA NA NA NA NA NA NA NA NA NA NA NAAdministrative NA NA NA NA NA NA NA NA NA NA NA NA

Survey NA NA NA NA NA NA NA NA NA NA NA NA







Indonesia - PcV3

2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018Estimate NA NA NA NA NA NA NA NA NA NA NA 8

Estimate GoC NA NA NA NA NA NA NA NA NA NA NA •Official NA NA NA NA NA NA NA NA NA NA NA 8

Administrative NA NA NA NA NA NA NA NA NA NA NA 8Survey NA NA NA NA NA NA NA NA NA NA NA NA






Description:

2018: Estimate based on coverage reported by national government. Pneumococcal conjugatevaccine partially introduced in 2017 with full roll out expected in 2019. Reporting beganin 2018. GoC=Assigned by working group. Consistency with GoC for other vaccines.


Indonesia - survey details

2016 Indonesia Laporan Nasional Riskesdas 2018

Vaccine Confirmation method Coverage Age cohort Sample Cards seenBCG Card or History 86.9 12-23 m 18165 35DTP1 Card or History 65.4 12-23 m 18165 35DTP3 Card or History 61.3 12-23 m 18165 35HepB1 Card or History 65.4 12-23 m 18165 35HepB3 Card or History 61.3 12-23 m 18165 35HepBB Card or History 83.1 12-23 m 18165 35Hib1 Card or History 65.4 12-23 m 18165 35Hib3 Card or History 61.3 12-23 m 18165 35MCV1 Card or History 77.3 12-23 m 18165 35MCV2 Card or History 38.3 24-35 m 18986 35Pol3 Card or History 67.6 12-23 m 18165 35

2012 Riset Kesehatan Dasar (RISKESDAS) 2013

Vaccine Confirmation method Coverage Age cohort Sample Cards seenBCG Card or History 87.6 12-23 m 15727 -DTP3 Card or History 75.6 12-23 m 15727 -HepB3 Card or History 75.6 12-23 m 15727 -MCV1 Card or History 82.1 12-23 m 15727 -Pol3 Card or History 77 12-23 m 15727 -

2011 Indonesia Demographic and Health Survey 2012

Vaccine Confirmation method Coverage Age cohort Sample Cards seenBCG C or H <12 months 88.6 12-23 m 3333 41BCG Card 39.7 12-23 m 1370 41BCG Card or History 89.3 12-23 m 3333 41BCG History 49.6 12-23 m 1963 41DTP1 C or H <12 months 87.6 12-23 m 3333 41DTP1 Card 40.2 12-23 m 1370 41DTP1 Card or History 88.1 12-23 m 3333 41DTP1 History 47.9 12-23 m 1963 41DTP3 C or H <12 months 70.6 12-23 m 3333 41

DTP3 Card 37 12-23 m 1370 41DTP3 Card or History 72 12-23 m 3333 41DTP3 History 35 12-23 m 1963 41HepB1 C or H <12 months 74 12-23 m 3333 41HepB1 Card 37.1 12-23 m 1370 41HepB1 Card or History 74.5 12-23 m 3333 41HepB1 History 37.5 12-23 m 1963 41HepB3 C or H <12 months 40.9 12-23 m 3333 41HepB3 Card 28.9 12-23 m 1370 41HepB3 Card or History 42.4 12-23 m 3333 41HepB3 History 13.6 12-23 m 1963 41HepBB C or H <12 months 84.8 12-23 m 3333 41HepBB Card 39.6 12-23 m 1370 41HepBB Card or History 85.3 12-23 m 3333 41HepBB History 45.7 12-23 m 1963 41MCV1 C or H <12 months 74.2 12-23 m 3333 41MCV1 Card 35.7 12-23 m 1370 41MCV1 Card or History 80.1 12-23 m 3333 41MCV1 History 44.4 12-23 m 1963 41Pol1 C or H <12 months 90.7 12-23 m 3333 41Pol1 Card 40.7 12-23 m 1370 41Pol1 Card or History 91.2 12-23 m 3333 41Pol1 History 50.5 12-23 m 1963 41Pol3 C or H <12 months 74.6 12-23 m 3333 41Pol3 Card 37.5 12-23 m 1370 41Pol3 Card or History 75.9 12-23 m 3333 41Pol3 History 38.4 12-23 m 1963 41

2009 Riset Kesehatan Dasar (RISKESDAS) 2010

Vaccine Confirmation method Coverage Age cohort Sample Cards seenBCG Card or History 77.9 12-23 m 4505 -DTP3 Card or History 61.9 12-23 m 4505 -HepB3 Card or History 61.9 12-23 m 4505 -MCV1 Card or History 74.4 12-23 m 4505 -Pol3 Card or History 66.7 12-23 m 4505 -

2006 Indonesia Demographic and Health Survey 2007



Vaccine Confirmation method Coverage Age cohort Sample Cards seenBCG C or H <12 months 84.4 12-23 m 3094 37BCG Card 34.6 12-23 m 3094 37BCG Card or History 85.4 12-23 m 3094 37BCG History 50.8 12-23 m 3094 37DTP1 C or H <12 months 82.9 12-23 m 3094 37DTP1 Card 35.8 12-23 m 3094 37DTP1 Card or History 84.4 12-23 m 3094 37DTP1 History 48.7 12-23 m 3094 37DTP3 C or H <12 months 64.3 12-23 m 3094 37DTP3 Card 31.2 12-23 m 3094 37DTP3 Card or History 66.7 12-23 m 3094 37DTP3 History 35.4 12-23 m 3094 37HepB1 Card or History 80.5 12-23 m 3094 37HepB3 Card or History 60.3 12-23 m 3094 37MCV1 C or H <12 months 67 12-23 m 3094 37MCV1 Card 30.9 12-23 m 3094 37MCV1 Card or History 76.4 12-23 m 3094 37MCV1 History 45.5 12-23 m 3094 37Pol1 C or H <12 months 87.2 12-23 m 3094 37Pol1 Card 35.9 12-23 m 3094 37Pol1 Card or History 89.2 12-23 m 3094 37Pol1 History 53.3 12-23 m 3094 37Pol3 C or H <12 months 71.1 12-23 m 3094 37Pol3 Card 32.3 12-23 m 3094 37Pol3 Card or History 73.5 12-23 m 3094 37Pol3 History 41.2 12-23 m 3094 37

2006 Report of Result of National Basic Health Research (RISKEDAS) 2007

Vaccine Confirmation method Coverage Age cohort Sample Cards seenBCG Card or History 86.9 12-23 m 438 23DTP3 Card or History 67.7 12-23 m 438 23HepB3 Card or History 62.8 12-23 m 438 23MCV1 Card or History 81.6 12-23 m 438 23Pol3 Card or History 71 12-23 m 438 23

2006 Republic of Indonesia Immunization Coverage Survey 2007

Vaccine Confirmation method Coverage Age cohort Sample Cards seenBCG Card or History 91 12-23 m 18204 52DTP1 Card or History 87 12-23 m 18204 52DTP3 Card or History 75 12-23 m 18204 52HepB3 Card or History 74 12-23 m 18204 52MCV1 Card or History 80 12-23 m 18204 52Pol3 Card or History 83 12-23 m 18204 52

2001 Indonesia Demographic and Health Survey 2002-2003

Vaccine Confirmation method Coverage Age cohort Sample Cards seenBCG Card 93.1 12-23 m 2819 31BCG Card or History 82.5 12-23 m 2819 31BCG History 77.8 12-23 m 2819 31DTP1 Card 93.8 12-23 m 2819 31DTP1 Card or History 81.4 12-23 m 2819 31DTP1 History 75.9 12-23 m 2819 31DTP3 Card 80.6 12-23 m 2819 31DTP3 Card or History 58.3 12-23 m 2819 31DTP3 History 48.4 12-23 m 2819 31MCV1 Card 70.9 12-23 m 2819 31MCV1 Card or History 71.6 12-23 m 2819 31MCV1 History 68.5 12-23 m 2819 31Pol1 Card 95.9 12-23 m 2819 31Pol1 Card or History 87.3 12-23 m 2819 31Pol1 History 83.5 12-23 m 2819 31Pol3 Card 87.9 12-23 m 2819 31Pol3 Card or History 66.1 12-23 m 2819 31Pol3 History 56.5 12-23 m 2819 31

2001 NID + Routine Coverage Survey

Vaccine Confirmation method Coverage Age cohort Sample Cards seenBCG Card or History 76.4 12-35 m - 66DTP1 Card or History 76.9 12-35 m - 66DTP3 Card or History 66.6 12-35 m - 66



HepB3 Card or History 62 12-35 m - 66MCV1 Card or History 69.5 12-35 m - 66

Pol3 Card or History 67.4 12-35 m - 66

Further information and estimates for previous years are available at:

http://www.data.unicef.org/child-health/immunization

http://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index4.html


Indonesia: WHO and UNICEF estimates of immunization ... · OFFICIAL coverage may di er across...

Documents

Transcript of Indonesia: WHO and UNICEF estimates of immunization ... · OFFICIAL coverage may di er across...